Patient Journey in Phosphate Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015510

Enrollment

100

Registered

2018-10-09

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E83.30

Interventions

Group 1: Single Arm Cross sectional trial Within a questionnaire medical history as well as clinical complaints will be identified and analyzed.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Evaluation will include all adult patients that were diagnosed with a hereditary form of phosphate wasting disorder

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Prevalcene of signs and symptoms in adult patients with phosphate diabetes in Germany	—

Secondary

Measure	Time frame
Quality of life in patients with phosphate diabetes Time from first symptoms to diagnosis Applied treatment modalities	—

Countries

Germany

Contacts

Public ContactLothar Seefried

Klinische StudieneinheitOrthopädische Klinik, Universität Würzburg

l-seefried.klh@uni-wuerzburg.de+49 931 803 3575

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026